Clinical Trial

A Phase 1 Study to Evaluate TGI-6 in Subjects With Locally Advanced/Metastatic Solid Tumors

Name: A Phase 1 Study to Evaluate TGI-6 in Subjects With Locally Advanced/Metastatic Solid Tumors — clinical trial record (NCT06374173)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A Phase 1 Study to Evaluate TGI-6 in Subjects with Locally Advanced/Metastatic Solid Tumors

Trial Details

NCT Number	NCT06374173
Lead Sponsor	Hefei TG ImmunoPharma Co., Ltd.
Conditions	Advanced or Metastatic Solid Tumors
Enrollment	123 participants
Start Date	2024-01-03
Primary Completion	2027-09 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2024-04-18